Rizatriptan Benzoate
- Product NDC
- 65862-625
- 11-digit product format
- 658620625
- Labeler code
- 65862
- Product ID
- 65862-625_b813e372-4315-4a35-a6dd-592b69aee7b8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rizatriptan Benzoate
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA203062
- Marketing category
- ANDA
- Marketing start
- 2013-07-01
- Substance
- RIZATRIPTAN BENZOATE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rizatriptan Benzoate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RIZATRIPTAN BENZOATE | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | WR978S7QHH |
| Rxcui | 312837, 312839 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 65862-625-03 | Rizatriptan Benzoate | 3 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 3 | | 14 |
| 65862-625-06 | Rizatriptan Benzoate | 6 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 6 | | 14 |
| 65862-625-12 | Rizatriptan Benzoate | 4 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 4 | | 14 |
| 65862-625-18 | Rizatriptan Benzoate | 3 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 3 | | 14 |
| 65862-625-36 | Rizatriptan Benzoate | 9 in 1 BOTTLE | TABLET, ORALLY DISINTEGRATING | 9 | | 14 |
| 65862-625-48 | Rizatriptan Benzoate | 18 in 1 BOTTLE | TABLET, ORALLY DISINTEGRATING | 18 | | 14 |
| 65862-625-64 | Rizatriptan Benzoate | 1 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 1 | | 14 |
| 65862-625-90 | Rizatriptan Benzoate | 3 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 3 | | 14 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 65862-625 | RIZATRIPTAN BENZOATE TABLET, ORALLY DISINTEGRATING [AUROBINDO PHARMA LIMITED] | 13 | Current NDC, Legacy NDC, 8 package rows | 20240221_a8e37688-426c-4290-933d-54a34ae86000.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 65862-625-03 | 65862062503 | 3 in 1 BLISTER PACK | | | | | | Historical |
| 65862-625-06 | 65862062506 | 6 in 1 BLISTER PACK | | | | | | Historical |
| 65862-625-12 | 65862062512 | 4 BLISTER PACK in 1 CARTON (65862-625-12) / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (65862-625-03) | 4 blister pack | 2013-07-01 | 0000-00-00 | No | No | Current |
| 65862-625-18 | 65862062518 | 3 BLISTER PACK in 1 CARTON (65862-625-18) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (65862-625-06) | 3 blister pack | 2013-07-01 | 0000-00-00 | No | No | Current |
| 65862-625-36 | 65862062536 | 9 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65862-625-36) | | 2018-03-05 | 0000-00-00 | No | No | Current |
| 65862-625-48 | 65862062548 | 18 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65862-625-48) | | 2018-03-05 | 0000-00-00 | No | No | Current |
| 65862-625-49 | 65862062549 | 4000 TABLET, ORALLY DISINTEGRATING in 1 BAG (65862-625-49) | | 01-JUL-13 | | | | Current |
| 65862-625-64 | 65862062564 | 1 BLISTER PACK in 1 CARTON (65862-625-64) / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (65862-625-03) | 1 blister pack | 2023-08-28 | | No | No | Current |
| 65862-625-90 | 65862062590 | 3 BLISTER PACK in 1 CARTON (65862-625-90) / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (65862-625-03) | 3 blister pack | 2013-07-01 | 0000-00-00 | No | No | Current |